TETRALOGIC PHARMACEUTICALS C - COM (TLOG)

CUSIP: 88165U109

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
5,876,047
Share change
-387,256
Total reported value
$10,166,000
Price per share
$1.73
Number of holders
31
Value change
-$704,171
Number of buys
9
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 88165U109?
CUSIP 88165U109 identifies TLOG - TETRALOGIC PHARMACEUTICALS C - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRALOGIC PHARMACEUTICALS C - COM (TLOG) as of Q4 2015

As of 31 Dec 2015, TETRALOGIC PHARMACEUTICALS C - COM (TLOG) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,876,047 shares. The largest 10 holders included Clarus Ventures, LLC, First Washington CORP, VANGUARD GROUP INC, First Eagle Investment Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, NEXTHERA CAPITAL LP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, HighTower Advisors, LLC, and Weiss Multi-Strategy Advisers LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.